Soon weight-loss drug Wegovy could be taken
Digest more
The convenience and lower cost of the oral pill may be critical to some patients, which could expand the market, improve adherence and boost long-term outcomes.
Novo Nordisk has launched its first oral GLP-1 weight-loss pill in the United States, expanding beyond injectable treatments that have reshaped the obesity
A pill version of the GLP-1 weight-loss drug Wegovy is expected to debut in the U.S. in early January. But how will the pills stack up against the already widely used injectables? Doctors in Western P
Analysis finds those who stopped using medication saw weight return four times faster compared with other weight loss plans